Pseudoprogression in patients on immunotherapy

Abstract

Now the number of patients receiving immunotherapy with checkpoint inhibitors is growing. At the same time, clinicians increasingly encounter such a clinical phenomenon as pseudoprogression. Nowadays we have no radiological evidences of pseudoprogression. The every such case requires an individual decision.

Keywords

• pseudoprogression
• immunotherapy
• анти-ctla4
• анти-pd-l1
• anti pd-1